Apple Watch Series 7 takes a step closer to offering a non-invasive glucose monitor and even an alcohol level sensor
Rockley Photonics Holdings Ltd has had its registration statement with the SEC published online, revealing interesting details about the firm ahead of it becoming a publicly traded company on the New York Stock Exchange. Rockley works on sensing products and technology mostly in regard to wearables and other mobile devices that have a health-related focus. Interestingly, the SEC filing reveals that the company’s largest customer is Apple Inc., so it is reasonable to suggest that Rockley’s expertise in the sensing field could be utilized in future Apple products, such as a potential Apple Watch Series 7.
This could mean that the successor to the Apple Watch Series 6 might end up with novel sensors such as a non-invasive blood glucose monitor, a lactate sensor, a carbon monoxide detector, and even an alcohol level indicator. The list actually doesn’t stop there, as Rockley mentions heart rate, body temperature, blood pressure, blood oxygen, breath rate, and hydration as all part of an overall system of “digital health monitoring”. Of course, it doesn’t mean an Apple Watch Series 7 could replace the advice of a medical professional, but it would give the user a better idea of their own personal health and wellbeing.
Similar rumors about an Apple Watch 7 (and other popular smartwatches and wearables) coming with a non-invasive blood glucose monitor have been reported on before. However, this recent development does indicate that sooner or later such technology will likely appear in an Apple wearable device. Such an Apple Watch could utilize Rockley’s “silicon photonics-based spectrometer chip”, which is vastly superior to LED-based solutions, to provide all the health-related data tracking a user could possibly ask for.